Dakota Wealth Management Lowers Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

Dakota Wealth Management reduced its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 6.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,230 shares of the financial services provider’s stock after selling 1,199 shares during the quarter. Dakota Wealth Management’s holdings in iShares Biotechnology ETF were worth $2,146,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also bought and sold shares of the company. Darwin Wealth Management LLC bought a new position in iShares Biotechnology ETF during the third quarter valued at approximately $29,000. Highline Wealth Partners LLC bought a new position in iShares Biotechnology ETF during the third quarter valued at approximately $30,000. Ashton Thomas Securities LLC bought a new position in iShares Biotechnology ETF during the third quarter valued at approximately $36,000. Modus Advisors LLC bought a new position in iShares Biotechnology ETF during the fourth quarter valued at approximately $41,000. Finally, Voisard Asset Management Group Inc. bought a new position in iShares Biotechnology ETF during the third quarter valued at approximately $59,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Trading Up 1.4 %

Shares of NASDAQ IBB opened at $138.25 on Friday. iShares Biotechnology ETF has a one year low of $123.60 and a one year high of $150.57. The firm’s 50 day simple moving average is $135.97 and its two-hundred day simple moving average is $141.78.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were issued a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.